Dena Hoffman posted

Will we all consider taking "diabetes drugs"?

There is early evidence - but not proof - that a new class of "diabetes drugs,"  SGLT2 inhibitors, may also help prevent cardiovascular disease and dementia. While the costs and side effects of these drugs are significant, we must recognize that cardiovascular (CV) disease and dementia challenge vast segments of the aging population.  Will we all consider taking these "diabetes drugs" as we age?